Over 25 Saudi Health Groups Spotlight Biotech Innovation at BIO Boston

Saudi Arabia's national pavilion at BIO 2025 features over 25 groups in health and science, spotlighting research potential and global biotech partnerships from June 16th to the 19th in Boston.
Saudi Arabia is participating in the 2025 BIO International Convention in Boston with a national pavilion led by the Ministry of Health. The Kingdom's delegation includes more than 25 organisations from across the government, private sector, and research community, marking one of its largest representations at the global biotech summit to date.
The delegation is taking part in exhibitions and high-level meetings focused on advancing biotechnology research, development, and investment. The event, widely recognised as the world's largest gathering of stakeholders in life sciences and medical innovation, runs through June 19th.
Saudi Arabia's presence aligns with its recently launched National Biotechnology Strategy, a key pillar of the country's broader push to expand its role in science, medicine, and high-tech industries. The strategy forms part of Saudi Vision 2030, which outlines major health sector transformation programmes and aims to position the Kingdom as a global hub for innovation.
The BIO Convention, hosted this year in Boston—a major centre for life sciences—offers a strategic platform for the Kingdom to showcase its advancements and attract international collaboration in emerging biotech fields.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Mid East Info

21 hours ago

• Mid East Info

The Department of Health – Abu Dhabi and Abbott Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi - Middle East Business News and Information

During BIO International Convention in Boston USA, the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Abbott, the global healthcare leader, entered a landmark partnership to localise manufacturing of pharmaceuticals in Abu Dhabi and advance digital health solutions. Leveraging Abu Dhabi's advanced life sciences infrastructure, this milestone reflects the emirate's proactive preparedness to reduce dependency on imports, strengthen supply chain resilience, and foster a sustainable, self-sufficient healthcare ecosystem. H.E. Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Following the recent launch of the Health, Endurance, Longevity and Medicine (HELM) Cluster in Abu Dhabi, the emirate proved to be equipped with a holistic, integrated infrastructure that fosters local manufacturing and R&D, positioning it as a regional healthcare gateway and leader in life sciences. By integrating our strategic vision with Abbott's expertise, we aim to accelerate the development and deployment of innovative healthcare products and solutions, reducing time-to-market, improving healthcare outcomes, and ensuring that breakthrough therapies reach patients faster. This approach positions Abu Dhabi as a regional leader in fostering an agile, innovation-driven healthcare ecosystem that directly translates scientific advancements into tangible benefits for our community.' The strategic collaboration outlines a comprehensive plan focusing on four key pillars including localisation of Abbott's pharmaceutical portfolio, biosimilar development, digital transformation through electronic patient information leaflets, and a robust education and workforce development initiative. Mazen Bachir, Regional Director for Abbott's established pharmaceuticals business in the Gulf, Emerging Markets and Levant said: 'Abbott is proud to announce a strategic collaboration with the Department of Health – Abu Dhabi, aimed at advancing healthcare resilience and innovation in Abu Dhabi. Building on Abbott's long-standing commitment to the UAE's healthcare system, this partnership will focus on localising existing pharmaceutical products, and jointly exploring the development of biosimilars, supported by regulatory alignment. The collaboration also includes initiatives to digitise life science product information through electronic leaflets in alignment with the UAE's digital health strategy. Another key component of this collaboration is the development of education programs to build local capabilities. Additionally, Abbott and the Department of Health will evaluate opportunities for joint research and development to strengthen long-term healthcare sustainability in the UAE.' Led by DoH, a high-level delegation has embarked on a strategic mission to the United States from June 15 to 21, 2025. The delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities and the signing of new agreements that accelerate the adoption of advanced health solutions.

Egypt Independent

2 days ago

• Egypt Independent

Iran accuses Israel of third hospital attack in Tehran

Iran's Ministry of Health has announced that the Israeli 'occupation' targeted a hospital in the capital, Tehran, marking the third such incident, according to international media reports. The Ministry stated that the 'Zionist entity' has struck six ambulances and a health services center since its 'aggression' against the country began. Last Friday, the Israeli 'occupation' launched attacks against various areas in Iran. These strikes were not limited to military zones; rather, the majority targeted residential areas, resulting in approximately 600 fatalities, mostly civilians, to date, according to international media. Separately, Iranian media reported that an Israeli drone targeted a residential building in central Tehran.

CairoScene

4 days ago

• CairoScene

Over 25 Saudi Health Groups Spotlight Biotech Innovation at BIO Boston

Saudi Arabia's national pavilion at BIO 2025 features over 25 groups in health and science, spotlighting research potential and global biotech partnerships from June 16th to the 19th in Boston. Saudi Arabia is participating in the 2025 BIO International Convention in Boston with a national pavilion led by the Ministry of Health. The Kingdom's delegation includes more than 25 organisations from across the government, private sector, and research community, marking one of its largest representations at the global biotech summit to date. The delegation is taking part in exhibitions and high-level meetings focused on advancing biotechnology research, development, and investment. The event, widely recognised as the world's largest gathering of stakeholders in life sciences and medical innovation, runs through June 19th. Saudi Arabia's presence aligns with its recently launched National Biotechnology Strategy, a key pillar of the country's broader push to expand its role in science, medicine, and high-tech industries. The strategy forms part of Saudi Vision 2030, which outlines major health sector transformation programmes and aims to position the Kingdom as a global hub for innovation. The BIO Convention, hosted this year in Boston—a major centre for life sciences—offers a strategic platform for the Kingdom to showcase its advancements and attract international collaboration in emerging biotech fields.